EP3937914
CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.3.2020EP published:
9.8.2023EP application number:
20712673.1
EPO information:
European Patent Register
Max expiry date:
12.3.2040
Title in English:
CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOIDLanguage of the patent:
English
Timeline
Today
13.3.2020EP application
9.8.2023EP Publication
Owner
Name:
LDN Pharma LimitedAddress:
45 Gresham Street, London EC2V 7BG, GB
Inventor
Name:
LIU, WaiAddress:
London EC2V 7BG, GB
Name:
DALGLEISH, AngusAddress:
London EC2V 7BG, GB
Priority
Number:
201903546Date:
15.3.2019Country:
GB
Classification
Categories:
A61K 31/05, A61K 31/08, A61K 31/192, A61K 31/352, A61K 31/485, A61K 45/06, A61P 35/00, A61K 31/555, A61K 31/7068